BeOne Medicines Plans $300M NJ Expansion, Bringing US Manufacturing Investment Over $1B


Editor’s Take: Whether based in the U.S. or globally, companies continue to seek opportunities to grow their business stateside.

BeOne Medicines is announcing a $300 million expansion of its clinical- and commercial-stage manufacturing and R&D center in Hopewell, NJ. This newest tranche of money takes BeOne’s United States manufacturing investment over $1 billion.

History of BeOne in NJ

The center, at the Princeton West Innovation Campus, opened in July 2024 on an initial investment of $800 million. A new, three-story, 145,000-square-foot building will bring the total campus footprint into the neighborhood of 545,000 square feet.

Over 42 acres, the site boasts more than 1 million square feet of developable real estate earmarked for future growth.

The expansion makes the campus a fully integrated, multi-platform manufacturing site combining existing biologics and new small molecule drug production.

Growing Manufacturing Capabilities

The added drug product manufacturing and packaging operations serve to strengthen BeOne’s production and supply chain capabilities. According to the company, this in turn supports a growing hematology portfolio and pipeline.

BeOne Medicines CEO Aaron Rosenberg weighed the impact of the announcement.

“[This] reflects BeOne’s commitment to strengthening U.S. manufacturing and expanding access to innovative medicines for patients with cancer,” Rosenberg said.

Not only President Donald Trump’s tax policies, Rosenberg said, but also NJ Governor Mikie Sherrill’s support of advanced manufacturing contributed.

In particular, the “Next New Jersey Manufacturing Program,” according to Rosenberg, encourages high-quality job creation.

“Together, these efforts create an environment for long-term growth,” Rosenberg said. “We are proud to continue expanding our global footprint in support of patients.”

The newly announced BeOne facility should be operational in 2029, the company says; subsequently, U.S. headcount will number approximately 240.

Free Training

Source link

Is Apple bringing chip manufacturing home? – Computerworld


TSMC doubles down

That’s why it is significant that TSMC confirmed plans to extend its own manufacturing in America. It already has a $165 billion US commitment; now, it is investing an additional $100 billion in four more chip plants — including one dedicated to churning out the company’s most advanced 2nm (and smaller) processors. 

“We believe this investment will help to further foster the development of the US semiconductor ecosystem, strengthen the supply chain, and support an increasing number of high-tech, high-paying jobs in the United States,”  CEO C.C. Wei told analysts.

TSMC has also confirmed plans to invest in packaging facilities for processors, which is basically the process where memory, processor, and networking nodes can all be combined and packaged on the chip. That sort of packaging is needed to make the final SoC chip. That means TSMC factories in the US will be able to churn out the advanced processors used in Apple’s current and, presumably, future devices.

Free Training

Source link

Taiwan’s Foxlink Group picks Fort Worth for first U.S. AI Factory, bringing 900 jobs to AllianceTexas


When the Taiwanese Foxlink Group sought to establish its first facility in the U.S., the company came to Fort Worth, Texas.

Foxlink Group, a global advanced technology manufacturer, has purchased Alliance Gateway 17 at the burgeoning AllianceTexas, where it will establish a new printed circuit board assembly (PCBA) manufacturing operation expected to create approximately 900 jobs at full capacity. The company celebrated its grand opening Tuesday. 

The company acquired the 147,780-square-foot facility at 4600 Alliance Gateway Freeway as part of an expansion of its U.S. manufacturing footprint.

Production is expected to begin in August.

Foxlink said the facility will be converted into an advanced manufacturing site supporting key phases of its surface mount technology (SMT) and final assembly, testing and packaging (FATP) production processes. The operation will integrate AI-driven robotics and intelligent automation directly on the production floor.

According to the company, the facility is designed for long-term scalability and will serve as a replicable model for Foxlink’s AI Factory deployments across its global manufacturing network.

“The launch of our Texas facility marks a monumental milestone in Foxlink’s steadfast commitment to the U.S. market,” Freddy Kuo, CEO of Foxlink Group, said in a statement. “We are deploying Physical AI directly on the production floor — embedding intelligent automation into every workstation, enabling flexible manufacturing that can be replicated rapidly across our global sites. This is not just a new factory. It is Foxlink’s first AI Factory in the United States, and it will not be the last.”

Founded in 1986, Foxlink Group designs and manufactures high-precision components for technology brands around the world. The company said it is also advancing the use of Physical AI through its subsidiaries — SYNCROBOTIC, UBILINK, and Luminys — which integrate AI-driven robotics, high-performance computing, and intelligent security solutions into its manufacturing operations.

Kuo added that the company’s expansion in Texas reflects its belief that the manufacturing solutions it develops internally can also be deployed for customers around the world.

Foxlink said it selected AllianceTexas because of its strategic location, transportation access, skilled workforce, and proximity to North Texas’ growing advanced manufacturing ecosystem.

Located within Hillwood’s 27,000-acre AllianceTexas development, the site offers access to major regional transportation corridors and infrastructure designed to support large-scale industrial and manufacturing operations.

The project adds to continued advanced manufacturing investment at AllianceTexas, which is home to more than 600 companies, more than 73,000 direct jobs and an estimated $142.9 billion in regional economic impact since 1989.

Foxlink noted that recent investments in the development include AI supercomputing facilities and MP Materials’ rare earth magnet manufacturing campus, which is under construction.

“Foxlink’s decision to establish its new U.S. AI Factory at AllianceTexas reinforces the strength of our platform for advanced manufacturing,” said Jack Barkley, vice president at Hillwood. “This transaction reflects what global manufacturers need — strategic location, infrastructure, workforce access, and connectivity that support speed, scale, and long-term growth.”

Free Training

Source link

Bauducco® Opens Largest U.S. Manufacturing Facility in Zephyrhills, Florida, Bringing 75 Years of Brazilian Baking Craftsmanship to American Tables | Press Releases


The iconic Brazilian brand — beloved for its cookies, wafers, and specialty baked goods — makes a landmark U.S. investment, deepening its commitment to American consumers and strengthening a retail partnership built on a larger domestic production.

ZEPHYRHILLS, Fla., June 26, 2026 /PRNewswire/ — For three generations, Bauducco® has done one thing exceptionally well: make food worth sharing. Its Wafer Cookies — layered, crisp, and impossible to eat just one of — have been a staple of Brazilian households for decades. Its rich cream-filled cookies, classic butter biscuits, and beloved seasonal specialties have traveled from pantries in São Paulo to celebrations across more than 50 countries. Today, that story takes its most ambitious chapter yet.

Bauducco® officially opened the doors to its largest U.S. manufacturing facility at 40334 6th Ave, in Zephyrhills, Florida. The 160,000-square-foot facility brings state-of-the-art production technology and double the manufacturing capacity previously available for the American market under one roof — streamlining the supply chain, shortening lead times, and enabling Bauducco® to respond to retail demand with greater speed and precision than ever before. The campus is designed to scale beyond 1.2 million square feet of production and distribution capacity as the company’s U.S. footprint grows, making today’s opening not just a milestone but a foundation — the most permanent and ambitious commitment Bauducco® has ever made to American consumers.

Founded in 1952, Bauducco® built its reputation on a deceptively simple idea: that the best baked goods require no shortcuts. The company’s U.S. wafer portfolio reflects that philosophy at every layer. The signature Wafer Cookies — available in chocolate, vanilla, strawberry, and coconut, and across multiple formats including a 40g single-serve, a 5oz multipack, a 9oz Family Pack, and a Sugar Free line in 5oz and 4.2oz — are made with a proprietary process that has remained largely unchanged since the brand’s earliest days. The result is a product that has achieved something rare in the snack category: genuine loyalty across generations.

The plant brings Bauducco®’s full wafer lineup under a Made in USA designation for the first time, operating at double the production capacity of what the brand previously had available for the American market. The demand signal was clear. What Bauducco® needed was the infrastructure to meet it — and now they have it.

The decision to build that infrastructure in the United States was not made quickly. For a family-owned company with deep roots in Brazil, it was a question of identity as much as strategy: was Bauducco® ready to make the expansion and build out the portfolio?

The answer, ultimately, was yes. And it’s expanding with a bet on Florida.

Zephyrhills — a growing community in the heart of Pasco County, northeast of Tampa — offered the combination of infrastructure, workforce, and community character that Bauducco®’s leadership was looking for. Pasco County’s economic development team was a key partner in making the case, helping to connect the company’s expansion vision with the resources and relationships needed to turn it into reality. The company expects the facility to employ over 600 people at full production capacity, making it one of the more significant food manufacturing employers in Pasco County.

“Bauducco’s decision to expand in Zephyrhills and create 600 jobs is a tremendous win for Pasco County. These are the kinds of opportunities that change lives and provide quality jobs for our residents while strengthening our local economy. We are proud that a globally recognized brand like Bauducco sees Pasco County as a place where it can grow and succeed, and we look forward to supporting their continued success for many years to come.” – Bill Cronin, President/CEO, Pasco Economic Development Council

The State of Florida and local government played an equally important role in bringing the project to life, with support that reflected the kind of public-private collaboration that Bauducco®’s leadership says made the decision clear.

“Today marks an exciting milestone for the City of Zephyrhills. We are proud to welcome Bauducco Foods and celebrate the opening of its largest U.S. manufacturing facility right here in Zephyrhills. Bauducco’s investment brings new high-wage jobs, strengthens our local economy, and further demonstrates the momentum taking place throughout our growing Industrial Corridor. Beyond its investment, Bauducco has already demonstrated a commitment to our city through its support of local organizations, events, and initiatives. On behalf of the Zephyrhills City Council and our residents, we are honored that this globally recognized company chose Zephyrhills for this important expansion and look forward to a long and successful partnership that will benefit our community for years to come.” – Melonie Bahr Monson, Mayor, City of Zephyrhills

For Stefano Mozzi, Bauducco®’s recently appointed Global CEO, the Zephyrhills facility is the physical expression of a strategic conviction he has championed since joining the company: that Bauducco®’s future in the United States depends on being present here in every sense of the word.

Speak to the vision behind this investment — why the U.S., why now, what this facility enables for the brand’s product quality and growth ambitions. Personal tone encouraged. Reference the brand’s 75-year legacy and what it means to bring that craftsmanship to American manufacturing. – Stefano Mozzi, Global CEO, Bauducco®

Bauducco®’s growth in the United States has been driven by retail partners who recognized early what American consumers were beginning to discover: that the brand’s commitment to quality was something worth putting on a shelf and standing behind. Those partnerships — built on consistent product performance, strong consumer pull, and a brand story that resonates across demographics — are now supported by something they have not had before: domestic production.

The Zephyrhills facility changes the equation for Bauducco®’s retail relationships in meaningful ways. Manufacturing on U.S. soil means shorter lead times, greater supply chain reliability, and the ability to respond to demand signals with speed and precision. For the retailers who have invested in the brand, it is a signal that Bauducco® is not here to test the market — it is here to serve it.

The facility also positions Bauducco® within a broader movement among major U.S. retailers to prioritize domestic sourcing and American-made products — a shift that has created new opportunities for brands willing to make the infrastructure investment to match.

“Bauducco’s investment in U.S. manufacturing is a strong example of how companies can create jobs, strengthen local communities and serve Walmart customers closer to home,” said Melody Richard, Senior Vice President, Pantry, Walmart U.S.

Bauducco® products are currently available at major retailers across the country, with the Zephyrhills facility expected to support expanded distribution and shelf presence as domestic production capacity grows. Bauducco® is the world’s largest producer of Panettone — a distinction earned over decades of perfecting the Italian-origin holiday bread that has become synonymous with the brand across more than 50 countries.

Bauducco® remains a family company. The founders’ descendants remain active in the business, and that ownership structure — with its long time horizons and personal stakes — is something company leaders say directly shaped the decision to invest at this scale in the United States.

The Zephyrhills facility is not a licensing arrangement or a co-manufacturing deal. It is Bauducco®’s own building, Bauducco®’s own lines, and Bauducco®’s own people. That distinction matters to a company that has always insisted on controlling what goes into every product it puts its name on.

For the Bauducco® family, today’s ceremony is a milestone measured not just in square footage and production capacity, but in what it represents across generations: the belief that something built carefully and honestly will always find its audience.

About Bauducco®

Founded in Brazil in 1952 by an Italian immigrant, Bauducco® is one of the world’s largest producers of baked goods, globally. Inspiring unforgettable moments with recipes crafted with innovation and passion, Bauducco®’s products are synonymous with The Feeling of Family. As a global company exporting to more than 50 countries, Bauducco® has been doing business in the U.S. for more than 20 years and has a national presence. Panettone, one of Bauducco®’s most iconic products, is a strategic player in the U.S. market, where the brand holds an 86% value share in this category. Bauducco® is the leading wafer producer nationwide. Bauducco®’s signature Panettones, Wafers, Cookies and Toasts are sold in most major retailers across the U.S. To learn more about Bauducco®, please visit www.bauducco.com and follow @bauducco.us on Instagram.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bauducco-opens-largest-us-manufacturing-facility-in-zephyrhills-florida-bringing-75-years-of-brazilian-baking-craftsmanship-to-american-tables-302812316.html

SOURCE Bauducco

Free Training

Source link

Bauducco® Opens Largest U.S. Manufacturing Facility in Zephyrhills, Florida, Bringing 75 Years of Brazilian Baking Craftsmanship to American Tables


The iconic Brazilian brand — beloved for its cookies, wafers, and specialty baked goods — makes a landmark U.S. investment, deepening its commitment to American consumers and strengthening a retail partnership built on a larger domestic production.

ZEPHYRHILLS, Fla., June 26, 2026 /PRNewswire/ — For three generations, Bauducco® has done one thing exceptionally well: make food worth sharing. Its Wafer Cookies — layered, crisp, and impossible to eat just one of — have been a staple of Brazilian households for decades. Its rich cream-filled cookies, classic butter biscuits, and beloved seasonal specialties have traveled from pantries in São Paulo to celebrations across more than 50 countries. Today, that story takes its most ambitious chapter yet.

Bauducco International Business Unit CEO and Bauducco family members are joined by the Zephyrhills Mayor and state and local officials for a ribbon cutting celebrating the grand opening of Bauducco's largest U.S. manufacturing facility in Zephyrhills, Florida.

Bauducco International Business Unit CEO and Bauducco family members are joined by the Zephyrhills Mayor and state and local officials for a ribbon cutting celebrating the grand opening of Bauducco’s largest U.S. manufacturing facility in Zephyrhills, Florida.

Bauducco® officially opened the doors to its largest U.S. manufacturing facility at 40334 6th Ave, in Zephyrhills, Florida. The 160,000-square-foot facility brings state-of-the-art production technology and double the manufacturing capacity previously available for the American market under one roof — streamlining the supply chain, shortening lead times, and enabling Bauducco® to respond to retail demand with greater speed and precision than ever before. The campus is designed to scale beyond 1.2 million square feet of production and distribution capacity as the company’s U.S. footprint grows, making today’s opening not just a milestone but a foundation — the most permanent and ambitious commitment Bauducco® has ever made to American consumers.

Founded in 1952, Bauducco® built its reputation on a deceptively simple idea: that the best baked goods require no shortcuts. The company’s U.S. wafer portfolio reflects that philosophy at every layer. The signature Wafer Cookies — available in chocolate, vanilla, strawberry, and coconut, and across multiple formats including a 40g single-serve, a 5oz multipack, a 9oz Family Pack, and a Sugar Free line in 5oz and 4.2oz — are made with a proprietary process that has remained largely unchanged since the brand’s earliest days. The result is a product that has achieved something rare in the snack category: genuine loyalty across generations.

The plant brings Bauducco®’s full wafer lineup under a Made in USA designation for the first time, operating at double the production capacity of what the brand previously had available for the American market. The demand signal was clear. What Bauducco® needed was the infrastructure to meet it — and now they have it.

The decision to build that infrastructure in the United States was not made quickly. For a family-owned company with deep roots in Brazil, it was a question of identity as much as strategy: was Bauducco® ready to make the expansion and build out the portfolio?

The answer, ultimately, was yes. And it’s expanding with a bet on Florida.

Zephyrhills — a growing community in the heart of Pasco County, northeast of Tampa — offered the combination of infrastructure, workforce, and community character that Bauducco®’s leadership was looking for. Pasco County’s economic development team was a key partner in making the case, helping to connect the company’s expansion vision with the resources and relationships needed to turn it into reality. The company expects the facility to employ over 600 people at full production capacity, making it one of the more significant food manufacturing employers in Pasco County.

“Bauducco’s decision to expand in Zephyrhills and create 600 jobs is a tremendous win for Pasco County. These are the kinds of opportunities that change lives and provide quality jobs for our residents while strengthening our local economy. We are proud that a globally recognized brand like Bauducco sees Pasco County as a place where it can grow and succeed, and we look forward to supporting their continued success for many years to come.” – Bill Cronin, President/CEO, Pasco Economic Development Council

The State of Florida and local government played an equally important role in bringing the project to life, with support that reflected the kind of public-private collaboration that Bauducco®’s leadership says made the decision clear.

“Today marks an exciting milestone for the City of Zephyrhills. We are proud to welcome Bauducco Foods and celebrate the opening of its largest U.S. manufacturing facility right here in Zephyrhills. Bauducco’s investment brings new high-wage jobs, strengthens our local economy, and further demonstrates the momentum taking place throughout our growing Industrial Corridor. Beyond its investment, Bauducco has already demonstrated a commitment to our city through its support of local organizations, events, and initiatives. On behalf of the Zephyrhills City Council and our residents, we are honored that this globally recognized company chose Zephyrhills for this important expansion and look forward to a long and successful partnership that will benefit our community for years to come.” – Melonie Bahr Monson, Mayor, City of Zephyrhills

For Stefano Mozzi, Bauducco®’s recently appointed Global CEO, the Zephyrhills facility is the physical expression of a strategic conviction he has championed since joining the company: that Bauducco®’s future in the United States depends on being present here in every sense of the word.

Speak to the vision behind this investment — why the U.S., why now, what this facility enables for the brand’s product quality and growth ambitions. Personal tone encouraged. Reference the brand’s 75-year legacy and what it means to bring that craftsmanship to American manufacturing. – Stefano Mozzi, Global CEO, Bauducco®

Bauducco®’s growth in the United States has been driven by retail partners who recognized early what American consumers were beginning to discover: that the brand’s commitment to quality was something worth putting on a shelf and standing behind. Those partnerships — built on consistent product performance, strong consumer pull, and a brand story that resonates across demographics — are now supported by something they have not had before: domestic production.

The Zephyrhills facility changes the equation for Bauducco®’s retail relationships in meaningful ways. Manufacturing on U.S. soil means shorter lead times, greater supply chain reliability, and the ability to respond to demand signals with speed and precision. For the retailers who have invested in the brand, it is a signal that Bauducco® is not here to test the market — it is here to serve it.

The facility also positions Bauducco® within a broader movement among major U.S. retailers to prioritize domestic sourcing and American-made products — a shift that has created new opportunities for brands willing to make the infrastructure investment to match.

“Bauducco’s investment in U.S. manufacturing is a strong example of how companies can create jobs, strengthen local communities and serve Walmart customers closer to home,” said Melody Richard, Senior Vice President, Pantry, Walmart U.S.

Bauducco® products are currently available at major retailers across the country, with the Zephyrhills facility expected to support expanded distribution and shelf presence as domestic production capacity grows. Bauducco® is the world’s largest producer of Panettone — a distinction earned over decades of perfecting the Italian-origin holiday bread that has become synonymous with the brand across more than 50 countries.

Bauducco® remains a family company. The founders’ descendants remain active in the business, and that ownership structure — with its long time horizons and personal stakes — is something company leaders say directly shaped the decision to invest at this scale in the United States.

The Zephyrhills facility is not a licensing arrangement or a co-manufacturing deal. It is Bauducco®’s own building, Bauducco®’s own lines, and Bauducco®’s own people. That distinction matters to a company that has always insisted on controlling what goes into every product it puts its name on.

For the Bauducco® family, today’s ceremony is a milestone measured not just in square footage and production capacity, but in what it represents across generations: the belief that something built carefully and honestly will always find its audience.

About Bauducco®
Founded in Brazil in 1952 by an Italian immigrant, Bauducco® is one of the world’s largest producers of baked goods, globally. Inspiring unforgettable moments with recipes crafted with innovation and passion, Bauducco®’s products are synonymous with The Feeling of Family. As a global company exporting to more than 50 countries, Bauducco® has been doing business in the U.S. for more than 20 years and has a national presence. Panettone, one of Bauducco®’s most iconic products, is a strategic player in the U.S. market, where the brand holds an 86% value share in this category. Bauducco® is the leading wafer producer nationwide. Bauducco®’s signature Panettones, Wafers, Cookies and Toasts are sold in most major retailers across the U.S. To learn more about Bauducco®, please visit www.bauducco.com and follow @bauducco.us on Instagram.

SOURCE Bauducco

Free Training

Source link

LGM Pharma Expands U.S. Manufacturing, Bringing Total Investment to $15M Across Texas and Colorado Sites


— $9M Second Phase of CDMO Investment Builds on 2025 $6M Expansion, Funding Facility Upgrades and Increased Capacity for Suppository, Semi-Solid, and Oral Solid Dose Capacity —

— Enhancements Strengthen Domestic Supply Chains for Finished Dose Manufacturing, Complementing Extensive API Sourcing and Analytical Testing Services —

BOCA RATON, Fla.–(BUSINESS WIRE)–#505b2–LGM Pharma, a leading provider of tailored API sourcing, contract analytical testing, and CDMO services for the full drug product lifecycle, today announced the second phase of its CDMO growth strategy, committing an additional $9 million to its facilities in Rosenberg, Texas, and Colorado Springs, Colorado. The investment follows the company’s previously announced $6 million expansion in Rosenberg in 2025 and is designed to increase commercial capacity, expand R&D capabilities, and support continued demand for U.S.-based drug product manufacturing.


The Texas facility enhancements include a $4 million investment to expand commercial-scale manufacturing suites for suppositories in response to increasing customer and market demand, including growth in women’s health products. The upgrades also expand R&D capabilities to support formulation and scale-up for suppositories, solutions, suspensions, and semi-solids. The Rosenberg site will remain fully operational throughout construction, with upgrades already underway.

In Colorado Springs, LGM Pharma will invest $5 million to expand commercial manufacturing capacity for niche, high-value oral solid dose (OSD) products, including orally disintegrating tablets (ODTs). The facility has served as the company’s center of excellence for OSD development. The expansion, planned for completion this year, will support growing demand for domestic manufacturing. In 2024, the global OSD CDMO market was valued at $43.65 billion, with North America accounting for approximately 40.5% of global OSD pharmaceutical manufacturing activity.1,2

“These multi-site investments totaling $15 million reflect our continued commitment to strengthening pharmaceutical supply chains in the United States,” said Prasad Raje, Chief Executive Officer of LGM Pharma. “Today’s pharma companies need partners that are both resilient and integrated across the full product lifecycle. By reinforcing domestic drug product manufacturing at the downstream end of the supply chain, closer to end markets, and leveraging our global API sourcing capabilities upstream, we create a balanced end-to-end model. This gives customers greater control and visibility as they move products from development to commercialization.”

Earlier in the supply chain, at the drug substance stage, LGM Pharma supports 505(b)(2), NDA, and ANDA programs through a global network of more than 220 pre-qualified API manufacturers. By combining global drug substance sourcing with expanded U.S. finished dose development and manufacturing, the company provides integrated support across the full drug product lifecycle.

Hamilton Lenox, Chief Commercial Officer of LGM Pharma, said the company’s prior Rosenberg upgrades from Phase I of the expansion, including implementation of enhanced track-and-trace serialization systems and increased production volumes, are now complete. “We are executing this next phase of expansion while keeping both facilities fully operational,” Lenox said. “Our teams are experienced in managing complex upgrades without sacrificing quality or disrupting customer supply, which remain our top operational priorities. Rather than overextending in a single phase, we are executing these enhancements incrementally to expand capabilities and capacity while ensuring operational continuity. This approach allows us to strengthen infrastructure, support customer growth, and scale in response to market demand.”

Companies developing 505(b)(2), NDA, or ANDA products, as well as those with commercial branded or generic portfolios, are encouraged to explore LGM Pharma’s API sourcing and expanded drug product manufacturing capabilities by visiting LGMPharma.com or meeting with company executives at DCAT Week, March 23-26, 2026, in New York City.

References:

  1. Grand View Research, “Oral Solid Dosage CDMO Market Size, Share & Trends Analysis Report,” [March 2024].
  2. Persistence Market Research, “Oral Solid Dosage Contract Manufacturing Market,” [May 2023].

About LGM Pharma

LGM Pharma is a leading contract development and manufacturing organization (CDMO) providing comprehensive Active Pharmaceutical Ingredient (API) sourcing, drug product CDMO services, and contract analytical testing services to the pharmaceutical, biotechnology, and compounding pharmacy industries. LGM Pharma assists clients in managing all phases of the drug product development process, from API sourcing through to drug product commercialization. LGM Pharma’s extensive global network of qualified API partners enables clients to optimize supply chain management and distribution. Services include API sourcing and procurement, formulation development, drug product manufacturing, analytical method development, method and process validation, ANDA/NDA submission, stability studies, and raw material and finished product testing and packaging. LGM Pharma is committed to quality and has a long-established positive regulatory track record, providing expert regulatory and market intelligence services to its clients. The company is focused on customer service and customized solutions, providing clients with a comprehensive U.S.-based manufacturing solution that reduces risk, increases efficiency, and accelerates the path to commercialization. For more information, visit LGMPharma.com.

Contacts

Media Contact:

Charya Wickremasinghe, Ph.D.

Brandwidth Solutions LLC

cwickremasinghe@brandwidthsolutions.com



Free Training

Source link